1. Home
  2. HALO vs WAL Comparison

HALO vs WAL Comparison

Compare HALO & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • WAL
  • Stock Information
  • Founded
  • HALO 1998
  • WAL 1994
  • Country
  • HALO United States
  • WAL United States
  • Employees
  • HALO N/A
  • WAL N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • WAL Major Banks
  • Sector
  • HALO Health Care
  • WAL Finance
  • Exchange
  • HALO Nasdaq
  • WAL Nasdaq
  • Market Cap
  • HALO 7.4B
  • WAL 7.8B
  • IPO Year
  • HALO N/A
  • WAL 2005
  • Fundamental
  • Price
  • HALO $49.48
  • WAL $80.30
  • Analyst Decision
  • HALO Buy
  • WAL Strong Buy
  • Analyst Count
  • HALO 9
  • WAL 15
  • Target Price
  • HALO $63.78
  • WAL $95.33
  • AVG Volume (30 Days)
  • HALO 2.1M
  • WAL 1.1M
  • Earning Date
  • HALO 05-06-2025
  • WAL 04-21-2025
  • Dividend Yield
  • HALO N/A
  • WAL 1.91%
  • EPS Growth
  • HALO 55.40
  • WAL 6.13
  • EPS
  • HALO 3.76
  • WAL 7.28
  • Revenue
  • HALO $1,084,306,000.00
  • WAL $3,049,400,000.00
  • Revenue This Year
  • HALO $20.06
  • WAL $13.35
  • Revenue Next Year
  • HALO $24.20
  • WAL $9.86
  • P/E Ratio
  • HALO $17.71
  • WAL $10.23
  • Revenue Growth
  • HALO 25.64
  • WAL 11.37
  • 52 Week Low
  • HALO $41.28
  • WAL $56.70
  • 52 Week High
  • HALO $70.51
  • WAL $98.10
  • Technical
  • Relative Strength Index (RSI)
  • HALO 36.86
  • WAL 65.78
  • Support Level
  • HALO $58.38
  • WAL $70.45
  • Resistance Level
  • HALO $69.94
  • WAL $75.71
  • Average True Range (ATR)
  • HALO 3.06
  • WAL 2.40
  • MACD
  • HALO -0.11
  • WAL 1.28
  • Stochastic Oscillator
  • HALO 6.60
  • WAL 87.00

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: